Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Stem cell therapy in chronic heart failure].

Hans D Theiss1, Wolfgang-M Franz

  • 1Medizinische Klinik und Poliklinik I der LMU, Klinikum der Universität München--Grosshadern, München.

Medizinische Klinik (Munich, Germany : 1983)
|January 19, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic impact of left- and right-atrial strain in patients undergoing transcatheter aortic valve replacement.

European heart journal. Cardiovascular Imaging·2024
Same author

Right ventricular function and dimensions in patients undergoing transcatheter aortic valve replacement assessed by three-dimensional echocardiography.

Clinical research in cardiology : official journal of the German Cardiac Society·2024
Same author

Aortic valved homograft degeneration: surgical or transcatheter approach for repeat aortic valve replacement?

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2024
Same author

Cardio-hepatic syndrome in patients undergoing transcatheter aortic valve replacement.

Clinical research in cardiology : official journal of the German Cardiac Society·2023
Same author

Systolic or diastolic CT image acquisition for transcatheter aortic valve replacement - An outcome analysis.

Journal of cardiovascular computed tomography·2022
Same author

Outcome of patients treated with extracorporeal life support in cardiogenic shock complicating acute myocardial infarction: 1-year result from the ECLS-Shock study.

Clinical research in cardiology : official journal of the German Cardiac Society·2020

Embryonic stem cells offer a promising future for treating chronic heart failure, potentially regenerating heart tissue when donor organs are scarce. Adult stem cells are in early clinical trials, but embryonic stem cells hold greater regenerative potential.

Area of Science:

  • Cardiovascular Medicine
  • Regenerative Medicine
  • Stem Cell Biology

Context:

  • Growing population of survivors from acute myocardial infarction (heart attack) progressing to chronic heart failure.
  • Limited therapeutic options for end-stage heart failure due to donor organ scarcity.

Purpose:

  • To explore stem cell therapy as a novel strategy for chronic heart failure.
  • To compare the potential of autologous and embryonic stem cells for cardiac repair.

Summary:

  • Current clinical studies investigate autologous stem cells for acute myocardial infarction and chronic heart failure, with uncertain efficacy.
  • Embryonic stem cells, due to their pluripotency and proliferation capacity, are ideal for in vitro tissue engineering.
  • In vitro-generated heart tissue from embryonic stem cells could be transplanted to improve cardiac function in chronic heart failure patients.

Related Experiment Videos

Impact:

  • While adult stem cells are in early clinical trials, embryonic stem cells are not yet clinically applied.
  • Embryonic stem cells show significant future potential for treating chronic heart failure and regenerating cardiac tissue.